Literature DB >> 2258137

Serum lipid levels in thyroid dysfunction with special reference to transient elevation during treatment in hyperthyroid Graves' disease.

H Nishitani1, K Okamura, S Noguchi, K Inoue, Y Morotomi, M Fujishima.   

Abstract

Lipid metabolism was examined in patients with hyper- or hypothyroidism. Compared with corresponding age and sex matched controls, serum total cholesterol (T-chol), low density lipoprotein cholesterol (LDL-chol), phospholipid (PL) and LDL levels were significantly low and free fatty acid (FFA) levels were high with apparently normal triglyceride (TG), very low density lipoprotein (VLDL) and high density lipoprotein cholesterol (HDL-chol) levels in 61 hyperthyroid patients, while T-chol, LDL-chol, TG, PL, VLDL and LDL levels were high with normal FFA and HDL-chol levels in 31 hypothyroid patients. Serum lipid levels were then repeatedly measured in 7 men and 7 women with hyperthyroid Graves' disease before treatment (stage I), just after the patients became euthyroid with anti-thyroid drug (stage II) and more than 2 months after the patients remained euthyroid (stage III). Serum T-chol, LDL-chol, PL and LDL levels were low at stage I, significantly elevated at stage II and then normalized at stage III. Transient but significant elevation of serum TG, VLDL and HDL-chol levels at stage II were also observed in men. Accelerated catabolism and anabolism of lipid has been reported in hyperthyroidism. Transient elevation of serum lipid levels suggests a more rapid improvement in catabolism than in anabolism of lipid in an early stage of the medical treatment for hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2258137     DOI: 10.1055/s-2007-1004953

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  3 in total

1.  Increased sensitivity to thyroid hormone replacement therapy followed by hyponatremia and eosinophilia in a patient with long-standing young-onset primary hypothyroidism.

Authors:  M Fujikawa; K Okamura; K Sato; T Mizokami; M Shiratsuchi; M Fujishima
Journal:  J Endocrinol Invest       Date:  1999-06       Impact factor: 4.256

2.  Carbohydrate response element binding protein gene expression is positively regulated by thyroid hormone.

Authors:  Koshi Hashimoto; Emi Ishida; Shunichi Matsumoto; Shuichi Okada; Masanobu Yamada; Teturou Satoh; Tsuyoshi Monden; Masatomo Mori
Journal:  Endocrinology       Date:  2009-03-26       Impact factor: 4.736

3.  Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease.

Authors:  Melpomeni Peppa; Grigoria Betsi; George Dimitriadis
Journal:  J Lipids       Date:  2011-07-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.